LINETTE EKE: Open Payments
NPI 1477074201 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 24 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $287 |
| Vanda Pharmaceuticals Inc. | 5 | $186 |
| Otsuka America Pharmaceutical, Inc. | 4 | $180 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Indivior Inc. | 1 | $31 |
| Lundbeck LLC | 1 | $27 |
Products named: CAPLYTA, REXULTI, FANAPT, HETLIOZ, ABILIFY ASIMTUFII, SPRAVATO, SUBLOCADE.
Industry payments across MD — which companies pay providers there.
